NIH Study Reveals New Mechanism of Mutant RAS Genes in Cancer Growth
NIH researchers reveal new insights into mutant RAS genes and their role in tumor growth, highlighting a previously unknown mechanism that could enhance cancer treatment strategies. Published in Nature Cancer, the study shows how mutant RAS proteins contribute to cancer development by transporting nuclear proteins, suggesting broader implications for various cancers. This groundbreaking discovery may lead to more effective combination therapies for RAS-driven malignancies.
Generation X Facing Alarming Increase in Cancer Incidence Compared to Baby Boomers, Study Finds
A recent study published in JAMA Network Open reveals that Generation X is experiencing larger per-capita increases in cancer incidence compared to Baby Boomers. Researchers found significant differences in invasive cancer trends between the two generations, with Generation X showing higher incidence rates for various cancers. The study highlights the need for continued research and efforts to address the rising cancer rates among younger generations.
Global Team Led by Dr. Yael Mossé Awarded Multimillion-Dollar Grant for Childhood Cancer Research
Dr. Yael Mossé and her global team have been awarded a multimillion-dollar grant to develop groundbreaking research in childhood cancer. The team aims to develop transformative new therapies for previously undruggable forms of childhood cancer, offering hope for improved treatment outcomes and quality of life for young patients.